Stay updated on Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Sign up to get notified when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A 403 Forbidden page is now displayed in place of the study record, presenting the standard error message and site chrome rather than the study details.
    Difference
    17%
    Check dated 2026-09-20T00:53:08.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.5 to v3.6.6, replacing the previous revision. This reflects a minor platform update rather than changes to study details or data.
    Difference
    0.1%
    Check dated 2026-08-29T19:37:58.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.6.4 to v3.6.5, indicating a background site update; no changes to the study details are shown.
    Difference
    0.1%
    Check dated 2026-08-08T13:27:52.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating a small internal update to the site's documentation or implementation.
    Difference
    0.1%
    Check dated 2026-07-25T06:26:49.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    New revision label v3.6.3 appears on the page, indicating a minor update to the page version. The study details and layout appear unchanged.
    Difference
    0.1%
    Check dated 2026-07-03T22:20:21.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The revision label now shows v3.6.2, replacing v3.6.0, indicating a backend/software update rather than a change to study information.
    Difference
    0.1%
    Check dated 2026-06-26T19:41:25.000Z thumbnail image

Stay in the know with updates to Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.